Pediatric Abdomen Imaging Guidelines (Coverage and Utilization)
Customize your policy alerts
Sign up for evicore Policy ABP.PX.0034.1.A alerts
Get alerted when Policy ABP.PX.0034.1.A changes without checking for updates manually.
Monitor payer policy activity
Coverage and utilization guidelines for pediatric abdominal imaging applied to Cigna-administered health benefit plans; intended to guide medical necessity determinations for providers and reviewers.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
inv-01: General Guidelines
Principles to guide appropriateness of advanced imaging in pediatric abdominal conditions.
Chunk 179
Chunk 179
Chunk 179
Chunk 180
Chunk 179
inv-02: Generalized Abdominal Pain
Covered when ALL of the following are met for children with generalized abdominal pain.
inv-03: Age-based applicability
Chunk 183
inv-04: Right Lower Quadrant Pain - Appendicitis
Covered when the following sequence and exceptions apply for suspected appendicitis.
Chunks 208,180
Chunk 208
Chunk 208
Chunk 208
inv-05: Flank Pain / Renal Stone
Covered when the following imaging pathway applies for flank pain or suspected renal/ureteral stone.
Chunks 215,180
Chunk 215
Chunk 215
inv-06: Upper Urinary Tract Imaging Criteria
Upper urinary tract imaging is covered when the following condition-specific criteria are met.
Chunk 219
Chunk 219
Chunk 219
Chunk 220
Chunks 219,220
inv-07: Lower Urinary Tract Imaging Criteria
Lower urinary tract imaging is covered when the following indications are present.
Chunk 222
Chunk 222
Chunk 222
Chunk 223
Chunk 222
inv-08: Acute Gastroenteritis Imaging Criteria
Imaging for pediatric acute gastroenteritis is covered only under limited circumstances.
Chunk 230
Chunks 230,179,180
Chunk 230
inv-09: Hematuria Imaging Criteria
Imaging for hematuria is covered according to the following scenarios.
Chunk 234
Chunk 234
Chunk 234
Chunk 234
inv-10: Hematuria — covered criteria (duplicate/alternate extraction)
Alternate presentation of hematuria criteria (condensed branches).
Chunk 234
Chunk 234
inv-11: Right Upper Quadrant Pain
Covered when diagnostic suspicion for biliary pathology exists and red flags are absent.
Chunk 238
inv-12: Inflammatory Bowel Disease (IBD)
Covered for suspected or established Crohn disease / IBD when specific clinical criteria are met.
Chunk 242
Chunks 243-244
Chunk 243
Chunk 244
Chunk 245
inv-13: Abdominal Sepsis (Suspected Abscess)
Imaging approach for suspected abdominal abscess mirrors adult guidance; follow adult abdominal sepsis criteria.
Chunk 250
inv-14: Postoperative Pain (PEDAB-11)
Medically necessary imaging options within 60 days postoperatively for suspected complications.
Chunk 254
Chunks 254,179
inv-15: Constipation/Diarrhea/IBS (PEDAB-12)
Advanced imaging is not routinely required for constipation, diarrhea, or IBS; CT is medically necessary only when red flags are present.
Chunk 258
inv-16: Abdominal Wall Mass (PEDAB-13.1)
Initial imaging options for a newly discovered abdominal wall mass.
Chunk 264
Chunk 264
inv-17: Intra-Abdominal Mass (PEDAB-13.2)
Approach to imaging for intra-abdominal masses in children.
Chunk 266
Chunk 266
This coverage policy applies to health benefit plans administered by Cigna and is intended to guide medical necessity determinations for pediatric abdominal imaging. Coverage decisions are made in the context of the member's applicable benefit plan document and relevant laws/regulations; when plan terms conflict with this guidance, the benefit plan document supersedes the policy. These guidelines were developed by eviCore to support interpretation of standard Cigna plans and are not treatment recommendations.
Services and studies listed in these guidelines apply to procedures managed by eviCore for Cigna per the payer's CPT code list; providers should confirm whether a requested CPT code is subject to eviCore review and follow any applicable prior authorization processes.
Unless a specific guideline section states otherwise, the use of advanced imaging to screen asymptomatic individuals for abdominal disorders is not supported. Advanced imaging should be reserved for individuals with documented active clinical signs or symptoms that are expected to affect management; imaging that will not change care is not indicated.
inv-138: Table of contents lists multiple pediatric abdominal indications; no criteria provided in excerpt (placeholder node)
Table of contents lists pediatric abdominal indications; specific criteria not included in this excerpt.
Chunks 18,36
inv-144: Red flag signs/symptoms — presence precludes standard adjudication
Presence of any of the following red flag signs/symptoms removes the requirement for initial ultrasound and directs to additional investigation.
Chunk 180
inv-145: Generalized abdominal pain — two top-level nodes (ultrasound-first vs red-flag exceptions)
Top-level guidance for generalized abdominal pain showing the two parallel pathways (ultrasound-first vs red-flag exceptions).
Chunks 195,180
Indications and Condition-Specific Guidance
Procedure Codes and Key Clinical Thresholds
| 74181 | MRI Abdomen without contrast |
| 74182 | MRI Abdomen with contrast (rarely used) |
| 74183 | MRI Abdomen without and with contrast |
| 76498 | Unlisted MRI procedure (for radiation planning or surgical software) |
| 74185 | MRA Abdomen |
| 74150 | CT Abdomen without contrast |
| 74160 | CT Abdomen with contrast |
| 74170 | CT Abdomen without and with contrast |
| 74176 | CT Abdomen and Pelvis without contrast |
| 74177 | CT Abdomen and Pelvis with contrast |
| 74183 | MRI abdomen without and with contrast — CPT ® 74183 (as listed) |
| 76770 | Ultrasound, abdominal, real time with image documentation; limited (e.g., single organ, quadrant), initial kidney ultrasound referenced |
| 76775 | Ultrasound, abdominal, real time with image documentation; complete, used for kidney ultrasound |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; limited (e.g., single organ) |
| 76857 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
| 78740 | Ureteral Reflux Study (Radiopharmaceutical Voiding Cystogram) / radionuclide cystography |
| 78707 | Renal scintigraphy; including diuretic renography (MAG3) - phase/protocol codes |
| 78708 | Renal scintigraphy additional code (MAG3) |
| 78709 | Renal scintigraphy additional code (MAG3) |
| 78700 | Renal cortical imaging, static (DMSA) |
| 78701 | Renal cortical imaging, static (DMSA) additional |
| 76770 | Ultrasound, scrotum and contents |
| 76775 | Ultrasound, retroperitoneal; complete |
| 76856 | Ultrasound, bladder |
| 76857 | Ultrasound, bladder with urethral pressure/flow (or bladder with Doppler?) |
| 74176 | CT abdomen and pelvis without contrast |
| 74177 | CT abdomen and pelvis with contrast |
| 72193 | CT pelvis with contrast - CT cystography / pelvic bladder contrast |
| 76377 | 3D rendering with interpretation |
| 76376 | 3D rendering (separate code listed) |
| 74183 | MR enterography / MRI abdomen and pelvis with and without contrast |
| 74181 | MRI abdomen without contrast |
| 72197 | MRI pelvis without and with contrast |
| 72195 | MRI pelvis, other (context: enterography pairing) |
| 74177 | CT enterography (CT abdomen and pelvis with contrast used for enterography) |
| 72196 | MRI pelvis with contrast |
| 78226 | HIDA scan |
| 76700 | Ultrasound Abdomen |
| 76705 | Ultrasound Abdomen (alternative CPT listed) |
| 74181 | MRI Abdomen without contrast |
| 74183 | MRI Abdomen without and with contrast |
| 72195 | MRI Pelvis without contrast |
| 72197 | MRI Pelvis without and with contrast |
| 74160 | CT Abdomen with contrast |
| 74150 | CT Abdomen without contrast |
| 74177 | CT Abdomen and Pelvis with contrast |
| 74176 | CT Abdomen and Pelvis without contrast |
Prior Authorization, Documentation, and Workflow
Prior authorization applicability — check Cigna CPT list
These guidelines include procedures that eviCore does and does not review for Cigna; providers must refer to the Cigna CPT code list for the current list of high‑tech imaging procedures that eviCore reviews for Cigna.
No prior authorization rules specified in TOC excerpt
The table of contents portion of this excerpt does not state prior authorization requirements; full prior authorization rules are located in the complete policy and payer-specific processes.
Prior authorization expectation for MRI/CT modalities
Prior authorization for advanced abdominal MRI/CT should follow the payer's rules; MRI abdomen is generally performed without and with contrast (CPT 74183) and CT abdomen/pelvis codes (e.g., CPT 74160, 74177) are referenced as condition-specific advanced imaging options.
Advanced imaging only after ultrasound or when conditions met
CT or MRI are appropriate only after ultrasound is inconclusive or when specified conditions exist (BMI ≥85th percentile, insufficient local ultrasound expertise, concern for complication); payer prior authorization may be required per policy for these advanced studies.
- Ultrasound should be initial imaging in most children prior to advanced imaging (chunk 179).
- Advanced imaging indicated when US inconclusive, BMI ≥85th percentile, insufficient US expertise, or complication suspected (chunk 208).
Prior authorization expectation for advanced pediatric abdominal studies
Certain advanced pediatric abdominal studies (e.g., CT, MRU, diuretic renography, DMSA, VCUG/radionuclide cystography) are described as medically necessary only for listed indications; documentation of indication is required when these studies are ordered.
- MRU (CPT 74183/72197) is not first‑line but medically necessary for investigation of a dilated upper urinary tract (chunk 220).
- Diuretic renography (CPT 78707/78708/78709) and DMSA (CPT 78700/78701/78803) have specific indications (chunk 219, 220).
- VCUG/radionuclide cystography (CPT 78740) is specified for reflux evaluation (chunk 219).
Submit CPT-coded imaging and clinical indication
When requesting imaging for pediatric abdominal indications, submit the specific CPT-coded study along with the clinical indication described in the guideline to support medical necessity.
- Providers should include the CPT code and supporting clinical details per the condition-specific guidance (e.g., hydronephrosis, recurrent febrile UTI, hematuria type) (chunks 234, 242).
Documentation required for listed CPT studies when seeking authorization
Imaging studies listed as medically necessary (CT, MRI, Ultrasound CPT codes in the guideline) require documentation of the indications described in the guideline (e.g., suspected postoperative complications, red flag symptoms, or characterization needs) when authorization is sought.
- Orders should reference postoperative timing (within 60 days), red flag signs/symptoms, or mass characterization needs as applicable (chunks 254, 264, 266).
Continue conservative management before advanced imaging
Continue conservative therapy prior to advanced imaging when the individual is improving on current treatment programs; advanced imaging is intended to answer clinical questions that will affect management.
- Imaging is not indicated if results will not affect individual management decisions (chunk 179).
Imaging step sequence — ultrasound first, then CT/MRI as indicated
Follow an imaging step sequence: ultrasound is the medically necessary initial modality for most pediatric abdominal pain presentations; CT or MRI are appropriate subsequent steps when ultrasound is inconclusive or other conditions exist.
- Ultrasound should be done prior to advanced imaging in most children (chunk 179).
- CT or MRI are medically necessary if ultrasound is inconclusive, BMI threshold met, insufficient local US expertise, or complication suspected (chunks 208, 215).
Ultrasound-first workflow for first-time pediatric UTI; follow-up per US findings
For first‑time pediatric UTI, ultrasound is the initial required study; follow-up testing (VCUG, radionuclide cystography, CeVUS) is guided by ultrasound findings and clinical context.
RUQ pain — US or HIDA first; MRI/CT if equivocal
For suspected RUQ biliary pathology, ultrasound (CPT 76700) or HIDA (CPT 78226/78227) is the initial approach; MRI (CPT 74183) or CT (CPT 74160) are medically necessary when ultrasound or HIDA are equivocal.
- Ultrasound results are not required prior to HIDA (chunk 238).
Modality sequencing for intra‑abdominal mass — ultrasound required first
For an intra‑abdominal mass, ultrasound (CPT 76700) is the required initial study; add Doppler (CPT 93975) to assess vascularity and proceed to CT/MRI based on ultrasound results and clinical context.
- Additional imaging determined by ultrasound findings, location, organ involvement, history, exam, and labs (chunk 266).
Reference member benefit plan and laws for coverage decisions
Providers must reference the member's specific benefit plan document and applicable laws/regulations when requesting coverage; the coverage policy is guidance used by medical directors for medical necessity determinations.
Required prior clinical evaluation before advanced imaging
A pertinent clinical evaluation (history, physical, appropriate labs, and basic imaging) should be performed prior to advanced imaging requests unless guideline‑supported scheduling or red flags exist.
- A meaningful technological contact (telehealth, phone, electronic messaging) can serve as the pertinent clinical evaluation (chunk 179).
Document red flag presence/absence — impacts adjudication
Document the presence or absence of red flag findings (e.g., fever >100.4°F, GI bleeding, guarding/rebound, abnormal WBC including ANC <1000, abdominal mass) because red flags preclude standard adjudication and may necessitate advanced imaging.
- Red flag presence removes requirement for initial ultrasound and triggers a different adjudication pathway (chunk 180).
- Any red flag per General Guidelines precludes adjudication based on other criteria (chunk 208).
Required documentation elements to justify advanced imaging
Include ultrasound results, BMI percentile when relevant, laboratory data, and clinical exam findings to support the need for advanced imaging and modality selection.
- If appendix not visualized on ultrasound and WBC not elevated, often no further imaging is necessary — document ultrasound and WBC (chunk 208).
- Preliminary labs may include CBC, electrolytes, lipase, amylase, urinalysis, ESR, CRP, LFTs as applicable (chunk 195).
Document clinical indication and ultrasound findings for urinary/hematuria imaging
Document clinical indication and relevant ultrasound findings (e.g., hydronephrosis, atypical or recurrent febrile UTI, hematuria type) when requesting modality‑specific studies like VCUG, MAG3, DMSA, CT, or MRU.
- Examples: hydronephrosis prompting VCUG; atypical/recurrent febrile UTI prompting DMSA or MAG3; hematuria type dictating US vs CT selection (chunks 219, 234).
Document inflammatory markers to support enterography for suspected IBD
Elevated inflammatory markers (fecal lactoferrin ≥4.0 µg/g, CRP >0.5 mg/dL, or fecal calprotectin ≥50 µg/g) support medical necessity for MR or CT enterography when Crohn disease is suspected.
- Enterography (MR or CT) is medically necessary when inflammatory markers meet listed thresholds or other listed criteria (chunk 243).
Include postoperative timing and indication for post‑op imaging requests
Orders for postoperative imaging should state the clinical indication and note postoperative timing (within 60 days) to justify CT/MRI/US studies for suspected complications.
Determinants of coverage decisions — check plan and laws
Coverage determinations consider the member's benefit plan terms, applicable laws/regulations, collateral materials, and case facts; the benefit plan document supersedes the coverage policy when conflicting.
Service coverage scope — managed CPT codes may require authorization
These guidelines apply to services and supplies managed by eviCore for Cigna as outlined by the Cigna CPT list; procedures outside the listed CPTs may not be supported and could lead to denial.
- Refer to the Cigna CPT list for which high‑tech imaging procedures eviCore reviews for Cigna (chunk 1).
- Procedure codes managed under these guidelines are listed in the procedure code table (chunk 175).
Denial risk: CT ordered before recommended ultrasound (no red flags)
Ordering CT abdomen for generalized abdominal pain when ultrasound is the recommended initial study and no red flags are present could lead to denial.
Red flags preclude standard adjudication — document and act accordingly
Presence of any red flag findings per General Guidelines precludes adjudication based on other criteria and triggers a different pathway for imaging decisions (may necessitate advanced imaging).
- Red flags include unexplained fever >100.4°F, GI bleeding, guarding/rebound, abnormal WBC including ANC <1000, abdominal mass, failure to thrive, jaundice, and others listed (chunk 180).
Prior Authorization Expectations
Contrast Use and Modality Notes
Repeat Imaging and Frequency Guidance
Background and Scope
These pediatric abdomen imaging guidelines are evidence-based coverage policies developed by eviCore to inform medical necessity determinations under standard Cigna benefit plans. They describe condition-specific modality sequencing (for example, recommending ultrasound as the initial study in most children) and when advanced modalities (CT, MRI, nuclear medicine) are appropriate.
Providers should treat the guideline as an interpretive coverage tool rather than a treatment guideline: document pertinent clinical evaluation (history, physical exam, labs, basic imaging) and the clinical question the imaging will address. The member's plan document and applicable laws/regulations govern final coverage decisions.
Key Definitions and Thresholds
Exclusions and Not Medically Necessary
The excerpt contains no exhaustive list of explicit technique- or indication-level exclusions; however, advanced imaging for asymptomatic screening of abdominal disorders is discouraged unless a condition-specific section explicitly supports screening. Additionally, imaging for uncomplicated presentations that will not change management is not supported.
Imaging is not considered medically necessary for asymptomatic microscopic hematuria without proteinuria. Ultrasound of the kidneys and bladder is indicated only when gross hematuria is present or when microscopic hematuria is accompanied by proteinuria or other concerning findings.
No additional explicit not-covered items are listed in the provided excerpt; the general rule remains that advanced imaging for asymptomatic screening is unsupported unless a guideline section specifically permits it.
There are no separate explicit exclusions in this excerpt beyond the general guidance that advanced imaging should not be used for asymptomatic screening and is not indicated when results will not affect individual management.
The guideline does not list further blanket exclusions in this excerpt; condition-specific sections may contain additional not-medically-necessary statements where applicable.
Absent condition-specific language permitting screening, requests for advanced imaging to investigate asymptomatic findings should be assessed for medical necessity and may be denied if they do not meet documented clinical indications.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.